Market by Product, Application, Source Type, and Country | Forecast 2021-2028
As stated in Triton’s report, the biosurgery market in the Middle East and Africa is likely to register growth based on revenue at a CAGR of 7.19% over the projected phase 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The countries considered for
analysis in this market are:
• The United Arab Emirates
• Turkey
• South Africa
• Saudi Arabia
• Rest of Middle East & Africa
The region’s growth is
influenced by the surge in the incidence rate of hip fractures, along with
increasing healthcare expenditure. Furthermore, the growing aging population
adds to the studied market’s growth across the region. In Saudi Arabia, in
recent years, there has been significant growth in the number of people over
the age of 65, which is likely to proliferate by 2050. This increase is
estimated to increase the incidence rate of chronic diseases, influencing the
demand for biosurgery products. Additionally, the launch of new products is
expected to boost the demand for biosurgery products. Hence, the rising burden
of chronic diseases, the growing geriatric population, and new product launches
are anticipated to drive the growth of the biosurgery market within Saudi
Arabia.
Likewise, the rising chronic
diseases have enhanced the number of surgical procedures across the UAE. Thus,
the patient pool for chronic conditions is expected to increase the demand for
biosurgery products. Additionally, the growing occurrence of cancer is likely
to increase the number of surgeries, adding to the growth of the studied
market. Besides, in recent years, bariatric surgeries have gained traction
across the country, influencing the demand for biosurgery products, leading to
the growth of the biosurgery market in the United Arab Emirates.
Baxter International Inc is a
healthcare company offering a wide range of healthcare products for chronic
dialysis therapies, infusion systems, inhaled aesthetics, parenteral nutrition,
surgical hemostat, and others. The company provides its products to hospitals,
nursing homes, rehabilitation centers, and kidney dialysis centers. Besides, it
markets its offering through a direct sales force, independent distributors,
and specialty pharmacies. Baxter has operations across multiple regions,
including the Middle East and Africa.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. MIDDLE
EAST AND AFRICA BIOSURGERY MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON BIOSURGERY MARKET
2.2. TRENDS
IN BIOSURGERY TECHNOLOGY
2.3. KEY
INSIGHTS
2.4. PORTER’S
FIVE FORCES MODEL
2.4.1. THREAT
OF NEW ENTRANTS
2.4.2. THREAT
OF SUBSTITUTE PRODUCTS
2.4.3. BARGAINING
POWER OF BUYERS
2.4.4. BARGAINING
POWER OF SUPPLIERS
2.4.5. COMPETITIVE
RIVALRY
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. KEY
BUYING OUTLOOK
2.8. KEY
MARKET STRATEGIES
2.8.1. CONTRACTS
AND PARTNERSHIPS
2.8.2. BUSINESS
EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES
2.8.3. ACQUISITIONS
& MERGERS
2.8.4. NEW
PRODUCT LAUNCHES & DEVELOPMENTS
2.9. MARKET
DRIVERS
2.9.1. GROWING
AGING POPULATION
2.9.2. SURGE
IN SURGICAL TREATMENTS FOR MUSCULOSKELETAL DISORDERS
2.9.3. PREVALENCE
OF SPINAL FUSION AND JOINT RECONSTRUCTION
2.9.4. STRONG
FOCUS ON RESEARCH AND DEVELOPMENT
2.10. MARKET
CHALLENGES
2.10.1. HIGH
COST OF SURGERIES
2.10.2. COMPLICATIONS
RELATED TO IMMUNE RESPONSE
2.10.3. USAGE
OF MINIMALLY INVASIVE SURGERIES
2.11. MARKET
OPPORTUNITIES
2.11.1. RESEARCH
AND INVESTMENTS IN BIOENGINEERING
2.11.2. DEVELOPMENT
OF POLICIES FOR REIMBURSEMENT AND COMPENSATION
3. MIDDLE
EAST AND AFRICA BIOSURGERY MARKET – BY PRODUCT
3.1. HEMOSTATIC
AGENTS
3.2. BONE-GRAFT
SUBSTITUTES
3.2.1. SYNTHETIC
GRAFT EXTENDERS
3.2.2. DEMINERALIZED
BONE MATRIX
3.2.3. BONE
MORPHOGENETIC PROTEINS
3.2.4. CELL-BASED
MATRICES
3.3. SURGICAL
SEALING AGENTS
3.3.1. NATURAL
3.3.2. SYNTHETIC
3.4. SOFT-TISSUE
MANAGEMENT
3.4.1. SYNTHETIC
MESH/PATCH
3.4.2. NATURAL
MESH/PATCH
3.5. ANTI-ADHESIVE
AGENTS
3.6. STAPLE
LINE REINFORCEMENT
4. MIDDLE
EAST AND AFRICA BIOSURGERY MARKET - BY APPLICATION
4.1. ORTHOPEDIC
SURGERY
4.2. CARDIO
AND THORACIC SURGERY
4.3. NEURO
AND SPINE SURGERY
4.4. GENERAL
SURGERY
4.5. OTHER
APPLICATIONS
5. MIDDLE
EAST AND AFRICA BIOSURGERY MARKET – BY SOURCE TYPE
5.1. NATURAL
5.2. SYNTHETIC
6. MIDDLE
EAST AND AFRICA BIOSURGERY MARKET – COUNTRY OUTLOOK
6.1. COUNTRY
ANALYSIS
6.1.1. SAUDI
ARABIA
6.1.2. UNITED
ARAB EMIRATES
6.1.3. TURKEY
6.1.4. SOUTH
AFRICA
6.1.5. REST
OF MIDDLE EAST & AFRICA
7. COMPETITIVE
LANDSCAPE
7.1. BAXTER
INTERNATIONAL INC
7.2. BECTON,
DICKINSON AND COMPANY
7.3. B
BRAUN MELSUNGEN AG
7.4. CSL
LIMITED
7.5. ETHICON
INC (JOHNSON & JOHNSON)
7.6. INTEGRA
LIFESCIENCES HOLDINGS CORPORATION
7.7. MEDTRONIC
PLC
7.8. RTI
SURGICAL
7.9. SANOFI
7.10. SMITH
& NEPHEW PLC
7.11. STRYKER
CORPORATION
7.12. WRIGHT
MEDICAL GROUP NV
7.13. ZIMMER
BIOMET HOLDINGS INC
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.1.1. OBJECTIVES
OF STUDY
8.1.2. SCOPE
OF STUDY
8.2. SOURCES
OF DATA
8.2.1. PRIMARY
DATA SOURCES
8.2.2. SECONDARY
DATA SOURCES
8.3. RESEARCH
METHODOLOGY
8.3.1. EVALUATION
OF PROPOSED MARKET
8.3.2. IDENTIFICATION
OF DATA SOURCES
8.3.3. ASSESSMENT
OF MARKET DETERMINANTS
8.3.4. DATA
COLLECTION
8.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: MIDDLE EAST AND
AFRICA BIOSURGERY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: CONTRACTS AND
PARTNERSHIPS
TABLE 4: BUSINESS EXPANSIONS,
ANNOUNCEMENTS, & DIVESTITURES
TABLE 5: ACQUISITIONS &
MERGERS
TABLE 6: NEW PRODUCT LAUNCHES
& DEVELOPMENTS
TABLE 7: MIDDLE EAST AND
AFRICA BIOSURGERY MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 8: MIDDLE EAST AND
AFRICA BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: MIDDLE EAST AND
AFRICA SURGICAL SEALING AGENTS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 10: MIDDLE EAST AND AFRICA
SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 11: MIDDLE EAST AND AFRICA
BIOSURGERY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 12: MIDDLE EAST AND AFRICA
BIOSURGERY MARKET, BY SOURCE TYPE, 2021-2028 (IN $ MILLION)
TABLE 13: MIDDLE EAST AND AFRICA
BIOSURGERY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
FIGURE 1: MIDDLE EAST AND AFRICA
BIOSURGERY MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: MIDDLE EAST AND AFRICA
BIOSURGERY MARKET, BY PRODUCT, 2020 & 2028 (IN %)
FIGURE 3: MIDDLE EAST AND AFRICA
BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2021-2028 (IN $ MILLION)
FIGURE 4: MIDDLE EAST AND AFRICA
BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 5: MIDDLE EAST AND AFRICA
BONE-GRAFT SUBSTITUTES MARKET, BY SYNTHETIC GRAFT EXTENDERS, 2021-2028 (IN $
MILLION)
FIGURE 6: MIDDLE EAST AND AFRICA
BONE-GRAFT SUBSTITUTES MARKET, BY DEMINERALIZED BONE MATRIX, 2021-2028 (IN $
MILLION)
FIGURE 7: MIDDLE EAST AND AFRICA
BONE-GRAFT SUBSTITUTES MARKET, BY BONE MORPHOGENETIC PROTEINS, 2021-2028 (IN $
MILLION)
FIGURE 8: MIDDLE EAST AND AFRICA
BONE-GRAFT SUBSTITUTES MARKET, BY CELL-BASED MATRICES, 2021-2028 (IN $ MILLION)
FIGURE 9: MIDDLE EAST AND AFRICA
BIOSURGERY MARKET, BY SURGICAL SEALING AGENTS, 2021-2028 (IN $ MILLION)
FIGURE 10: MIDDLE EAST AND AFRICA
SURGICAL SEALING AGENTS MARKET, BY NATURAL, 2021-2028 (IN $ MILLION)
FIGURE 11: MIDDLE EAST AND AFRICA
SURGICAL SEALING AGENTS MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION)
FIGURE 12: MIDDLE EAST AND AFRICA
BIOSURGERY MARKET, BY SOFT-TISSUE MANAGEMENT, 2021-2028 (IN $ MILLION)
FIGURE 13: MIDDLE EAST AND AFRICA
SOFT-TISSUE MANAGEMENT MARKET, BY SYNTHETIC MESH/PATCH, 2021-2028 (IN $ MILLION)
FIGURE 14: MIDDLE EAST AND AFRICA
SOFT-TISSUE MANAGEMENT MARKET, BY NATURAL MESH/PATCH, 2021-2028 (IN $ MILLION)
FIGURE 15: MIDDLE EAST AND AFRICA
BIOSURGERY MARKET, BY ANTI-ADHESIVE AGENTS, 2021-2028 (IN $ MILLION)
FIGURE 16: MIDDLE EAST AND AFRICA
BIOSURGERY MARKET, BY STAPLE LINE REINFORCEMENT, 2021-2028 (IN $ MILLION)
FIGURE 17: MIDDLE EAST AND AFRICA
BIOSURGERY MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 18: MIDDLE EAST AND AFRICA
BIOSURGERY MARKET, BY ORTHOPEDIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 19: MIDDLE EAST AND AFRICA
BIOSURGERY MARKET, BY CARDIO AND THORACIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 20: MIDDLE EAST AND AFRICA
BIOSURGERY MARKET, BY NEURO AND SPINE SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 21: MIDDLE EAST AND AFRICA
BIOSURGERY MARKET, BY GENERAL SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 22: MIDDLE EAST AND AFRICA
BIOSURGERY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 23: MIDDLE EAST AND AFRICA
BIOSURGERY MARKET, BY SOURCE TYPE, 2020 & 2028 (IN %)
FIGURE 24: MIDDLE EAST AND AFRICA
BIOSURGERY MARKET, BY NATURAL, 2021-2028 (IN $ MILLION)
FIGURE 25: MIDDLE EAST AND AFRICA
BIOSURGERY MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION)
FIGURE 26: SAUDI ARABIA BIOSURGERY
MARKET 2021-2028 (IN $ MILLION)
FIGURE 27: UNITED ARAB EMIRATES
BIOSURGERY MARKET 2021-2028 (IN $ MILLION)
FIGURE 28: TURKEY BIOSURGERY MARKET
2021-2028 (IN $ MILLION)
FIGURE 29: SOUTH AFRICA BIOSURGERY
MARKET 2021-2028 (IN $ MILLION)
FIGURE 30: REST OF MIDDLE EAST
& AFRICA BIOSURGERY MARKET 2021-2028 (IN $ MILLION)